Endoscopic Ultrasonography-Guided Fine Needle Aspiration of Kidney Masses

Abstract

Scan the quick response (QR) code to the left with your mobile device to watch this article's video abstract and others. Don't have a QR code reader? Get one by searching 'QR Scanner' in your mobile device's app store. clinical management strategy is based on imaging features. A solid, contrast-enhancing renal mass seen on CT or MRI is considered malignant until proven otherwise, and operative resection is undertaken in appropriate candi- dates. A histologic diagnosis remains necessary in selected patients, such as those with radiographically indetermi- nate lesions, in those considering partial nephrectomy, and to confirm malignancy in patients unfi tf or surgery. Tissue diagnosis is critical to discern appropriate treat- ment in this subgroup. Renal biopsies are usually per- formed percutaneously under transabdominal ultrasound (US) or CT guidance. Percutaneous fine needle aspiration (FNA) can discriminate benign from malignant neoplasms in 91% of cases with histologic classification of tumor type possible in 87% of tumors. 2 Nondiagnostic/inade- quate specimens are largely owing to sampling error and occur in about 30% of cases. Data from case reports and series suggest endoscopic ultrasound (EUS)-guided FNA may provide an additional diagnostic technique for tissue acquisition of renal mass lesions.